HeNan Sincere Biotech Co., Ltd   Report issue

For profit Phase 2 Phase 3
Founded: Beijing China (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2017
NCT04109183
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

HeNan Sincere Biotech Co., Ltd